£107.85

Springer Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days · 78 data points (no recent data)

Historical
Generating forecast…
£107.85 £102.46 £104.61 £106.77 £108.93 £111.09 £113.24 21 May 2026 09 June 2026 28 June 2026 17 July 2026 06 August 2026

Price Distribution

Price distribution over 78 days • 1 price levels

Days at Price
78 days 0 20 39 59 78 £108 Days at Price

Price Analysis

Most common price: £108 (78 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 78 days

Description

Experimental chemotherapy continues to be at the forefront of cancer thera peutics. Topics covered in the preceding volume on cancer chemotherapy in this series such as study of drugs by alkaline elution, the development of the antimetabolite tiazofurin, and the treatment of germ cell tumors have become informative references to current experimentalists and practitioners. In even earlier volumes, reviews of the platinum compounds, anthracyclines, and osteosarcoma represent topics associated with such rapid progress requiring a look back to provide the appropriate perspective. Similarly, we venture to predict that the topics in this volume will become useful landmarks for future drug development and disease strategies. In the area of drug development, what is being learned about old, estab lished antineoplastics is raising renewed expectations that it will be translated into improved applications and patient benefit. For example, we now have the ability to modulate the action of alkylating agents and fluorinated pyri midines to achieve greater sensitivity. A new compound for an old target, trimetrexate, an antifolate that does not polyglutaminate, will have a role not only in treatment of neoplastic diseases, but also protozoal infection.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
05 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
84% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Pharmaceutical Perspectives of Cancer Therapeutics
84% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
84% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 05 Aug 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
84% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£129.15 24 Jun 2026
Metronomic Chemotherapy: Pharmacology and Clinical Applications
84% match

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Springer

£81.78 06 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
83% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
83% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.88 06 Aug 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
82% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£84.04 04 Aug 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
82% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£76.42 07 Aug 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
82% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 04 Aug 2026
Cancer Drug Discovery: Science and History
82% match

Cancer Drug Discovery: Science and History

Springer

£113.76 05 Aug 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
82% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 12 Aug 2026
Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
82% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£113.97 07 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
82% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)
82% match

Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Springer

£107.98 07 Aug 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£108.01 06 Aug 2026
Oncologic Therapies
82% match

Oncologic Therapies

Springer

£81.74 05 Aug 2026
Nutraceuticals and Cancer
82% match

Nutraceuticals and Cancer

Springer

£113.76 05 Aug 2026
Molecular Targeted Therapy of Lung Cancer
82% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
82% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 06 Aug 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
81% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.11 06 Aug 2026
Penicillins and Cephalosporins: 5 (Chemotherapy, 5)
81% match

Penicillins and Cephalosporins: 5 (Chemotherapy, 5)

Springer

£78.05 08 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
81% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 08 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
81% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 05 Aug 2026